Literature DB >> 21163350

Monitoring protein aggregation and toxicity in Alzheimer's disease mouse models using in vivo imaging.

Tara L Spires-Jones1, Alix de Calignon, Melanie Meyer-Luehmann, Brian J Bacskai, Bradley T Hyman.   

Abstract

Aggregation of amyloid beta peptide into senile plaques and hyperphosphorylated tau protein into neurofibrillary tangles in the brain are the pathological hallmarks of Alzheimer's disease. Despite over a century of research into these lesions, the exact relationship between pathology and neurotoxicity has yet to be fully elucidated. In order to study the formation of plaques and tangles and their effects on the brain, we have applied multiphoton in vivo imaging of transgenic mouse models of Alzheimer's disease. This technique allows longitudinal imaging of pathological aggregation of proteins and the subsequent changes in surrounding neuropil neurodegeneration and recovery after therapeutic interventions.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163350      PMCID: PMC3049845          DOI: 10.1016/j.ymeth.2010.12.009

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  41 in total

1.  A pyramid approach to subpixel registration based on intensity.

Authors:  P Thévenaz; U E Ruttimann; M Unser
Journal:  IEEE Trans Image Process       Date:  1998       Impact factor: 10.856

2.  Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.

Authors:  Monica Garcia-Alloza; Sarah A Dodwell; Melanie Meyer-Luehmann; Bradley T Hyman; Brian J Bacskai
Journal:  J Neuropathol Exp Neurol       Date:  2006-11       Impact factor: 3.685

3.  Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

Authors:  Tara L Spires-Jones; Melanie Meyer-Luehmann; Jennifer D Osetek; Phillip B Jones; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

4.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

5.  Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

Authors:  Brian J Bacskai; Stephen T Kajdasz; Megan E McLellan; Dora Games; Peter Seubert; Dale Schenk; Bradley T Hyman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

6.  Fluorescent Arc/Arg3.1 indicator mice: a versatile tool to study brain activity changes in vitro and in vivo.

Authors:  Valery Grinevich; Alexander Kolleker; Marina Eliava; Naoki Takada; Hiroshi Takuma; Yugo Fukazawa; Ryuichi Shigemoto; Dietmar Kuhl; Jack Waters; Peter H Seeburg; Pavel Osten
Journal:  J Neurosci Methods       Date:  2009-07-21       Impact factor: 2.390

Review 7.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

8.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

9.  Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations.

Authors:  Julianne A Lombardo; Edward A Stern; Megan E McLellan; Stephen T Kajdasz; Gregory A Hickey; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2003-11-26       Impact factor: 6.167

10.  Experience leaves a lasting structural trace in cortical circuits.

Authors:  Sonja B Hofer; Thomas D Mrsic-Flogel; Tobias Bonhoeffer; Mark Hübener
Journal:  Nature       Date:  2008-11-12       Impact factor: 49.962

View more
  12 in total

Review 1.  Are tangles as toxic as they look?

Authors:  Tara L Spires-Jones; Katherine J Kopeikina; Robert M Koffie; Alix de Calignon; Bradley T Hyman
Journal:  J Mol Neurosci       Date:  2011-06-03       Impact factor: 3.444

2.  Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging.

Authors:  Robert M Koffie; Christian T Farrar; Laiq-Jan Saidi; Christopher M William; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Development and screening of contrast agents for in vivo imaging of Parkinson's disease.

Authors:  Krista L Neal; Naomi B Shakerdge; Steven S Hou; William E Klunk; Chester A Mathis; Evgueni E Nesterov; Timothy M Swager; Pamela J McLean; Brian J Bacskai
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

4.  Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.

Authors:  Darius Ebrahimi-Fakhari; Ippolita Cantuti-Castelvetri; Zhanyun Fan; Edward Rockenstein; Eliezer Masliah; Bradley T Hyman; Pamela J McLean; Vivek K Unni
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

5.  APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.

Authors:  Katherine L Youmans; Leon M Tai; Evelyn Nwabuisi-Heath; Lisa Jungbauer; Takahisa Kanekiyo; Ming Gan; Jungsu Kim; William A Eimer; Steve Estus; G William Rebeck; Edwin J Weeber; Guojun Bu; Chunjiang Yu; Mary Jo Ladu
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

6.  Alzheimer's disease: synapses gone cold.

Authors:  Robert M Koffie; Bradley T Hyman; Tara L Spires-Jones
Journal:  Mol Neurodegener       Date:  2011-08-26       Impact factor: 14.195

7.  A Peephole into the Brain: Neuropathological Features of Alzheimer's Disease Revealed by in vivo Two-Photon Imaging.

Authors:  Sabine Liebscher; Melanie Meyer-Luehmann
Journal:  Front Psychiatry       Date:  2012-04-02       Impact factor: 4.157

Review 8.  Aluminum-induced amyloidogenesis and impairment in the clearance of amyloid peptides from the central nervous system in Alzheimer's disease.

Authors:  Yuhai Zhao; James M Hill; Surjyadipta Bhattacharjee; Maire E Percy; Aileen I D Pogue; Walter J Lukiw
Journal:  Front Neurol       Date:  2014-09-05       Impact factor: 4.003

9.  Clustering of plaques contributes to plaque growth in a mouse model of Alzheimer's disease.

Authors:  Joanna F McCarter; Sabine Liebscher; Teresa Bachhuber; Claudia Abou-Ajram; Mark Hübener; Bradley T Hyman; Christian Haass; Melanie Meyer-Luehmann
Journal:  Acta Neuropathol       Date:  2013-06-18       Impact factor: 17.088

Review 10.  Microglia as a critical player in both developmental and late-life CNS pathologies.

Authors:  Noël C Derecki; Natalie Katzmarski; Jonathan Kipnis; Melanie Meyer-Luehmann
Journal:  Acta Neuropathol       Date:  2014-07-24       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.